Saveria Campo
#129,099
Most Influential Person Now
Italian viral oncologist
Saveria Campo's AcademicInfluence.com Rankings
Saveria Campophilosophy Degrees
Philosophy
#10567
World Rank
#14493
Historical Rank
Logic
#7432
World Rank
#9187
Historical Rank
Download Badge
Philosophy
Saveria Campo's Degrees
- Bachelors Biology University of Milan
- Masters Biomedical Sciences University of Milan
Similar Degrees You Can Earn
Why Is Saveria Campo Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maria Saveria Campo FRSE , known as Saveria, is an Italian viral oncologist, known for being the first person to demonstrate an effective papillomavirus vaccine. She developed the vaccine alongside her colleague at the University of Bristol, England, Dr. Richard B.S. Roden. She went on to be recognized for her work and was awarded the position of Fellow of the Royal Society of Edinburgh in 2006. She has worked continuously in the field of Oncology up until her retirement.
Saveria Campo's Published Works
Published Works
- Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. (1996) (341)
- Animal models of papillomavirus pathogenesis. (2002) (281)
- Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups (1993) (265)
- Papillomavirus E5: the smallest oncoprotein with many functions (2011) (229)
- E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I (2005) (219)
- Association of bovine papillomavirus with the equine sarcoid. (2003) (209)
- Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. (2008) (208)
- Association of bovine papillomavirus type 2 and bracken fern with bladder cancer in cattle. (1992) (200)
- Bovine papillomavirus and cancer. (1997) (157)
- E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain (2006) (135)
- A new papillomavirus associated with alimentary cancer in cattle (1980) (133)
- HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells. (2010) (127)
- Prophylactic and therapeutic vaccination against a mucosal papillomavirus. (1993) (126)
- Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins (2002) (121)
- Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. (1991) (120)
- A Functional Interaction between the Human Papillomavirus 16 Transcription/Replication Factor E2 and the DNA Damage Response Protein TopBP1* (2002) (112)
- Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world (1995) (109)
- Papillomavirus research: from natural history to vaccines and beyond. (2006) (109)
- Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. (1995) (100)
- Latent papillomavirus infection in cattle. (1994) (100)
- Human papillomavirus DNA in biopsies of oral tissues. (1991) (97)
- Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. (2003) (93)
- Phenotypical characterization of lymphocytes infiltrating regressing papillomas (1996) (90)
- A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. (1984) (89)
- Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. (1994) (89)
- The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface (2002) (89)
- Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. (1981) (86)
- Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. (1996) (86)
- Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types (1990) (84)
- Bovine papillomavirus: old system, new lessons? (2006) (83)
- Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. (2006) (78)
- The presence of bovine papillomavirus type 4 DNA is not required for the progression to, or the maintenance of, the malignant state in cancers of the alimentary canal in cattle. (1985) (78)
- Comparative Analysis of Transforming Properties of E6 and E7 from Different Beta Human Papillomavirus Types (2011) (75)
- Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination (1990) (73)
- Papillomas and cancer in cattle. (1987) (70)
- The detection of Bovine Papillomavirus type 1 DNA in flies. (2009) (70)
- Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor β receptor in naturally occurring bovine urinary bladder tumours (2006) (68)
- Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches (2009) (68)
- A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease. (1997) (67)
- Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. (1974) (62)
- Bovine Papillomavirus Type 1 DNA and E5 Oncoprotein Expression in Water Buffalo Fibropapillomas (2009) (62)
- Vaccination against papillomavirus in cattle. (1997) (62)
- The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts (1996) (59)
- Papillomavirus and disease in humans and animals. (2003) (56)
- Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. (1974) (54)
- Analysis of the transforming functions of bovine papillomavirus type 4. (1993) (54)
- The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame (1991) (54)
- The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. (2008) (52)
- Generation of native bovine mAbs by phage display. (1999) (52)
- Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the south of Italy. (2003) (52)
- Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions. (2007) (50)
- Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. (2007) (49)
- Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. (2008) (49)
- Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. (1997) (48)
- Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids (1978) (47)
- Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. (1990) (46)
- All 4 di‐leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization (2010) (46)
- Papillomaviruses: a correlation between immune evasion and oncogenicity? (2003) (46)
- The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1 (1995) (46)
- Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. (2007) (44)
- Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2 (1981) (43)
- Expression of cell cycle associated proteins cyclin A, CDK-2, p27kip1 and p53 in equine sarcoids. (2005) (42)
- Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain. (2010) (40)
- Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. (1992) (39)
- The nucleotide sequence and genome organization of bovine papillomavirus type 4. (1987) (39)
- Quercetin, E7 and p53 in papillomavirus oncogenic cell transformation. (2001) (38)
- Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain. (2009) (37)
- Downregulation of major histocompatibility complex class I in bovine papillomas. (2004) (37)
- Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. (1990) (36)
- An Enhanced Epithelial Response of a Papillomavirus Promoter to Transcriptional Activators* (1999) (36)
- Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive. (2010) (36)
- Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. (2008) (36)
- Transcriptional control signals in the genome of bovine papillomavirus type 1 (1983) (35)
- Conservation of cytoplasmic poly(A)-containing RNA in mouse and rat (1975) (35)
- Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region (1995) (34)
- Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. (2008) (33)
- Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure. (2014) (32)
- Transcriptional Changes Induced by Bovine Papillomavirus Type 1 in Equine Fibroblasts (2008) (32)
- Quercetin elevates p27Kip1 and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1 (2003) (32)
- Infection by bovine papillomavirus and prospects for vaccination. (1995) (32)
- Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. (1982) (32)
- The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus (2006) (31)
- HPV and oesophageal carcinoma. (2006) (31)
- Alimentary fibropapilloma in cattle: a spontaneous tumor, nonpermissive for papillomavirus replication. (1984) (31)
- Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts. (2011) (30)
- Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus (1981) (30)
- Molecular cloning and characterization of human papillomavirus type 7 DNA. (1986) (30)
- BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1 (1998) (30)
- Cell Transformation by the E5/E8 Protein of Bovine Papillomavirus Type 4 (2001) (27)
- The Harvey ras 1 gene is activated in papillomavirus-associated carcinomas of the upper alimentary canal in cattle. (1990) (27)
- The BPV-4 co-carcinogen quercetin induces cell cycle arrest and up-regulates transcription from the LCR of BPV-4 (1998) (27)
- E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. (2001) (27)
- DNA-RNA hybridization. (1975) (27)
- Extensive papillomatosis of the bovine upper gastrointestinal tract. (2003) (27)
- Cell transformation by animal papillomaviruses. (1992) (26)
- Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. (1994) (26)
- DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. (1986) (26)
- Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts. (2010) (25)
- Cooperation between papillomavirus and chemical cofactors in oncogenesis. (1993) (24)
- Role of different sponge cell types in species specific cell aggregation. (1971) (24)
- Quercetin induces structural chromosomal aberrations and uncommon rearrangements in bovine cells transformed by the E7 protein of bovine papillomavirus type 4. (2003) (24)
- Vaccination against papillomavirus. (1991) (23)
- A multimeric L2 vaccine for prevention of animal papillomavirus infections. (2011) (22)
- Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule. (1991) (22)
- A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4. (1999) (22)
- Characterization of a nuclear factor, papilloma enhancer binding factor‐1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity (1993) (22)
- T cell responses to BPV-4 E7 during infection and mapping of T cell epitopes. (1995) (22)
- Bovine papillomaviruses and equine sarcoids. (2006) (21)
- Papillomavirus infection in cattle: viral and chemical cofactors in naturally occurring and experimentally induced tumours. (1986) (21)
- The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I. (2006) (20)
- Molecular Cloning of Bovine Papillomavirus Genomes and Comparison of Their Sequence Homologies by Heteroduplex Mapping (1982) (20)
- The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. (1995) (19)
- Viral and cellular oncogenes in papillomavirus-associated cancers. (1988) (19)
- Human papillomavirus research: Do we still need animal models? (2009) (19)
- Epidemiology of human papillomavirus infections and associations with cervical cancer: new opportunities for prevention. (2006) (18)
- Vaccination against papillomavirus in cattle. (1997) (18)
- Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. (2005) (17)
- The E5 protein of papillomaviruses (2002) (17)
- A Novel Silencer Element in the Bovine Papillomavirus Type 4 Promoter Represses the Transcriptional Response to Papillomavirus E2 Protein (2001) (16)
- Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. (1983) (16)
- Epithelial specific transcriptional regulation of the bovine papillomavirus 4 promoter by E2. (1998) (15)
- The biology of papillomaviruses and their role in oncogenesis. (1985) (15)
- Bovine papillomavirus type 4. (1996) (15)
- Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53 (2012) (14)
- p38 mitogen-activated protein kinase is crucial for bovine papillomavirus type-1 transformation of equine fibroblasts. (2011) (14)
- Interaction between bovine papillomavirus type 4 and cocarcinogens in the production of malignant tumours. (1993) (14)
- Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells. (2006) (14)
- The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome. (1997) (14)
- Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts. (2009) (13)
- The cutaneous human papillomavirus types and non-melanoma skin cancer. (2006) (12)
- Bacterial expression and purification of recombinant bovine Fab fragments. (2002) (12)
- Vaccination of Cattle with L2 Protein Prevents BPV-4 Infection (1994) (12)
- Down-regulation of MHC class I in bovine papillomas (2004) (12)
- Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4. (1997) (12)
- Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals (1989) (11)
- Papillomaviruses and their involvement in oncogenesis. (1985) (11)
- Papillomas of the teats and udder of cattle and their causal viruses (1984) (11)
- The genomes of bovine papillomaviruses types 3 and 4 are colinear. (1983) (10)
- Transcriptional organization of bovine papillomavirus type 4. (1986) (10)
- Cyclin A expression and growth in suspension can be uncoupled from p27 deregulation and extracellular signal-regulated kinase activity in cells transformed by bovine papillomavirus type 4 E5. (2004) (10)
- Multiple Harvey-ras genes in the bovine genome. (1989) (10)
- E 5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H M-ATPase (9)
- Amplification of specific DNA sequences in C127 mouse cells transformed by bovine papillomavirus type 4. (1989) (9)
- Equine sarcoids are not induced by an infectious cell line. (2007) (9)
- Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein. (2005) (9)
- Sequence homologies between bovine papillomavirus genomes mapped by a novel low-stringency heteroduplex method. (1985) (9)
- Mapping of two novel transcripts of bovine papillomavirus type 4. (1988) (8)
- 1st International Workshop on Papillomavirus E5 Oncogene-a report. (2010) (8)
- Upregulation of equine matrix metalloproteinase 1 by bovine papillomavirus type 1 is through the transcription factor activator protein-1. (2011) (8)
- HPV vaccines in plants: an appetising solution to control infection and associated cancers. (2006) (7)
- alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. (2000) (7)
- Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. (1991) (7)
- HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment. (2005) (6)
- HPV and cancer: the story unfolds. (1998) (6)
- The bovine papillomavirus type 4 long control region contains an epithelial specific enhancer. (1999) (6)
- Antibody response to E6, E7, and L1 proteins of human papillomavirus 16 in an Italian population (1994) (6)
- Assignment of the bovine p53 gene (TP53) to Chromosome 19q15 by fluorescence in situ hybridization (1995) (5)
- Detection and Identification of Papillomaviruses in Benign and Malignant Tumours of Cattle (1984) (5)
- Vaccination against cutaneous and mucosal papillomavirus in cattle. (1994) (4)
- Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. (1970) (4)
- PEF-1, an epithelial cell transcription factor which activates the long control region of human papillomavirus type 16, is glycosylated with N-acetylglucosamine. (1998) (4)
- Warts and all (1982) (4)
- Linking human papillomaviruses to cervical cancer: a long and winding road. (2006) (4)
- Papillomavirus research: a growth area. (1984) (3)
- BPV-4 induces amplification and activation of 'silent' BPV-1 in a sub-line of C127 cells. (1993) (2)
- Cooperation between Bovine Papillomaviruses and Dietary Carcinogens in Cancers of Cattle (1995) (2)
- A new cytoplasmic ribonucleoprotein particle in the cellular slime mold, Dictyostelium purpureum. (1970) (2)
- Virus Escape from Immunosurveillance (2002) (2)
- Recurrent respiratory papillomatosis, HPV, and impact on host response. (2006) (2)
- Ribosomal subunits in Dictyostelium discoideum. The effect of an ionic detergent and a nonionic detergent. (1969) (2)
- Human papillomavirus 16 L 2 inhibits the transcriptional activation function , but not the DNA replication function , of HPV 16 E 2 (2006) (2)
- The tumour promoter TPA enhances the transformation to the TK+ phenotype of la cells transfected with chimaeric plasmids without interaction with the bovine papillomavirus regulatory sequences (1986) (1)
- RIBOSOMAL SUBUNIT EXCHANGE IN DICTYOSTELIUM PURPUREUM (1970) (1)
- International Workshop on Papillomavirus E 5 Oncogene — A report (2010) (1)
- Serological Response to HPV16 Infection (1994) (0)
- Review article Cell transformation by animal papillomaviruses (1992) (0)
- Studies on transcription in cultured rat myoblasts (1973) (0)
- R-loop mapping of RNA transcripts from bovine papillomavirus type 4. (1988) (0)
- Cordano, P. and Gillan, V. and Bratlie, S. and Bouvard, V. and Banks, L (2008) (0)
- Pharmaceutical compositions based on papillomaviruses (1994) (0)
- Short and sweet Oncogenes and Tumour Suppressor Genes (1991). By P. Macdonald and C. H. J. Ford. Bios Scientific Publishers: Oxford. 112pp. £11.95/$24 p'back (1992) (0)
This paper list is powered by the following services:
Other Resources About Saveria Campo
What Schools Are Affiliated With Saveria Campo?
Saveria Campo is affiliated with the following schools: